← Leaderboards
Jian Yang
University Of Texas Arlington
$5,791,905
Attributed
$8,024,555
Total exposure
9
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–23$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$8,024,555 · 9
By mechanism
R01$6,985,589 · 6
R21$813,966 · 2
R41$225,000 · 1
Top collaborators
- Kytai Truong Nguyen6 shared
- Jer-Tsong Hsieh5 shared
- Zhiwen Liu2 shared
- Ralph P Mason2 shared
- Maoqi Mark Feng1 shared
Others in their field
Top investigators on “Biocompatible Materials”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$109,756,899
- Thomas T Perls · Beth Israel Deaconess Medical Center$38,971,164
- Jonathan S Lewin · Case Western Reserve University$37,486,163
- Sean McSweeney · Brookhaven Science Assoc-Brookhaven Lab$36,732,078
- Daniel H Geschwind · University Of California Los Angeles$35,924,551
- Ravi Thadhani · Brigham And Women'S Hospital$32,923,409
Research focus
Biocompatible MaterialsIn VivoBaseCellsPropertyInnovationPolymersNanoparticleDesignAreaStem CellsAnimal ModelScaffoldTissue EngineeringImageBiomaterial CompatibilityMonitorIn VitroUptakeIn SituEvaluationNanotechnologyDrug Delivery SystemsBiodegradable Polymer
Grant awards (27)
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$59,714
R01 · FY2023 · HL
Novel nanoparticles to stimulate therapeutic angiogenesis in peripheral arterial disease$536,747
R01 · FY2022 · HL
Photoacoustic and epigenetic nerve scaffold for nerve regeneration$429,412
R01 · FY2022 · NS · contact PI
Citrate Metabonegenic Regulation for the next Generation of Orthopedic Biomaterial Design$340,680
R01 · FY2022 · AR · contact PI
Citrate Metabonegenic Regulation for the next Generation of Orthopedic Biomaterial Design$333,955
R01 · FY2021 · AR · contact PI
Citrate Metabonegenic Regulation for the next Generation of Orthopedic Biomaterial Design$344,440
R01 · FY2020 · AR · contact PI
Citrate Metabonegenic Regulation for the next Generation of Orthopedic Biomaterial Design$344,591
R01 · FY2019 · AR · contact PI
STTR Phase I Development of Novel Antibacterial and Antifungal Bioadhesive Biomaterials for Diabetic Skin Wound Healing$225,000
R41 · FY2019 · DK
Citrate Metabonegenic Regulation for the next Generation of Orthopedic Biomaterial Design$344,738
R01 · FY2018 · AR · contact PI
Chromatic two-photon fluorescence microsopy using band-shifting imaging probes$184,791
R21 · FY2018 · EB
Novel Engineered Particle Platform for Endothelium Regeneration$395,497
R01 · FY2017 · HL
Developing targeted therapy with prostate cancer specific nanomedicine$314,920
R01 · FY2017 · CA
Chromatic two-photon fluorescence microsopy using band-shifting imaging probes$224,808
R21 · FY2017 · EB
Novel Engineered Particle Platform for Endothelium Regeneration$346,194
R01 · FY2016 · HL
Developing targeted therapy with prostate cancer specific nanomedicine$315,210
R01 · FY2016 · CA
Novel Engineered Particle Platform for Endothelium Regeneration$365,926
R01 · FY2015 · HL
Developing targeted therapy with prostate cancer specific nanomedicine$312,584
R01 · FY2015 · CA
Novel Engineered Particle Platform for Endothelium Regeneration$353,763
R01 · FY2014 · HL
Creating Safe Biodegradable Photoluminescent Implant Polymers$309,018
R01 · FY2014 · EB · contact PI
Developing targeted therapy with prostate cancer specific nanomedicine$303,466
R01 · FY2014 · CA
Developing targeted therapy with prostate cancer specific nanomedicine$327,859
R01 · FY2013 · CA
Creating Safe Biodegradable Photoluminescent Implant Polymers$289,509
R01 · FY2013 · EB · contact PI
Creating Safe Biodegradable Photoluminescent Implant Polymers$272,106
R01 · FY2012 · EB · contact PI
Creating Safe Biodegradable Photoluminescent Implant Polymers$33,022
R01 · FY2012 · EB · contact PI
Creating Safe Biodegradable Photoluminescent Implant Polymers$312,238
R01 · FY2011 · EB · contact PI
Enabling aliphatic biodegradable photoluminescent polymeric biomaterials$183,225
R21 · FY2010 · EB · contact PI
Enabling aliphatic biodegradable photoluminescent polymeric biomaterials$221,142
R21 · FY2009 · EB · contact PI